Paratek appoints new CFO
This article was originally published in Scrip
Executive Summary
Paratek Pharmaceuticals has appointed Douglas Pagan to its executive leadership team as chief financial officer, effective 18 December 2014. Mr Pagan will report to Michael F Bigham, chair and chief executive officer of Paratek. Most recently, Mr Pagan was vice-president of finance at Acceleron Pharma, which he joined in 2008.